Drug recall · March 13, 2024
Clindamycin Phosphate Topical Solution USP recall
Why: Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60
- Lots / codes
Lot #: 119874; Exp 06/30/2025
- Quantity
- 11,750 bottles
- Company
- Contract Pharmaceuticals Limited Canada, Mississauga
- Distribution
- Nationwide in the U.S. and Puerto Rico
- Initiated
- February 20, 2024 · Voluntary: Firm initiated
- Classified
- March 1, 2024
- Reported
- March 13, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clindamycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.